The Hepatitis D Virus (HDV) PCR Detection Kit is a high-performance real-time RT-qPCR assay designed for the quantitative detection of HDV RNA in human samples. Utilizing advanced hydrolysis probe (TaqMan®) technology, the assay enables highly sensitive and specific identification of HDV in clinical specimens.
Targeting conserved regions of the HDV genome, the kit ensures accurate detection of viral RNA, even at low concentrations. An integrated internal control system supports validation of RNA quality and detection of potential PCR inhibition, ensuring reliable and reproducible results.
With optimized one-step RT-qPCR chemistry and compatibility across major real-time PCR platforms, this kit provides an efficient and dependable solution for clinical diagnostics and viral load monitoring.
The HDV PCR Detection Kit is an in-vitro diagnostic real-time RT-qPCR assay developed for the quantitative identification of Hepatitis D virus RNA. The assay utilizes hydrolysis probe technology to amplify and detect specific viral targets with high sensitivity and specificity.
The kit includes a ready-to-use master mix containing primers and probes for HDV detection, supporting accurate quantification of viral load in clinical samples.
Hepatitis D virus (HDV) is a defective single-stranded RNA virus that requires the presence of Hepatitis B virus (HBV) for replication. Infection occurs as either co-infection or superinfection in individuals with HBV and is associated with more severe liver disease.
HDV infection significantly increases the risk of cirrhosis, liver failure, and hepatocellular carcinoma. Transmission occurs primarily through exposure to infected blood or body fluids. Accurate molecular detection and quantification are essential for disease monitoring and treatment management.
The assay is designed for precise and sensitive quantification of HDV RNA in clinical samples such as serum and plasma (K2EDTA). One-step RT-qPCR enables reverse transcription and amplification in a single reaction, improving workflow efficiency and reducing handling time.
Hydrolysis probe-based detection ensures high specificity, while optimized assay conditions provide robust and reproducible performance across a wide dynamic range. The assay supports reliable viral load measurement for clinical decision-making.
Instructions for Use